Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-03-10 @ 8:06 PM
Study NCT ID:
NCT05322720
Status:
UNKNOWN
Last Update Posted:
2022-04-12
First Post:
2022-03-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
Sponsor:
Taizhou EOC Pharma Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EOC202A2102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None